CVR number 25942507
Industry 32.5000 Manufacture of medical and dental instruments and supplies

FJORDBLINK MEDICAL ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  2.2% 2.2% 2.2% 2.2% 2.2%  
Bankruptcy risk  6.1% 7.6% 4.5% 22.4% 5.2%  
Credit score (0-100)  38 31 46 3 43  
Credit rating  BBB BB BBB B BBB  
Credit limit (kDKK)  0.0 0.0 0.0 -0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Gross profit  1,393 1,422 2,575 -304 1,646  
EBITDA  377 103 943 -2,459 -756  
EBIT  377 103 943 -2,542 -922  
Pre-tax profit (PTP)  305.5 55.6 797.7 -2,648.5 -1,040.7  
Net earnings  305.5 55.6 797.7 -2,648.5 -842.7  
Pre-tax profit without non-rec. items  306 55.6 798 -2,649 -1,041  
 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Tangible assets total  0.0 0.0 0.0 342 243  
Shareholders equity total  676 732 1,530 -1,119 1,938  
Interest-bearing liabilities  1,870 1,559 3,117 5,004 4,181  
Balance sheet total (assets)  3,991 2,992 5,189 4,561 7,513  
Net Debt  1,870 1,559 3,117 5,004 4,181  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,393 1,422 2,575 -304 1,646  
Gross profit growth  138.7% 2.0% 81.1% 0.0% 0.0%  
Employees  0 0 0 4 4  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  3,991 2,992 5,189 4,561 7,513  
Balance sheet change%  29.3% -25.0% 73.4% -12.1% 64.7%  
Added value  376.7 103.0 943.4 -2,541.8 -755.8  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 260 -266  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 -1.0 -2.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  27.0% 7.2% 36.6% 835.5% -56.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  9.8% 3.0% 23.1% -46.7% -14.0%  
ROI %  18.3% 4.3% 27.2% -52.6% -16.6%  
ROE %  16.2% 7.9% 70.5% -87.0% -25.9%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  17.0% 24.5% 30.0% -20.3% 25.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  496.3% 1,513.0% 330.4% -203.5% -553.2%  
Gearing %  276.4% 213.0% 203.8% -447.3% 215.7%  
Net interest  0 0 0 0 0  
Financing costs %  4.1% 2.8% 6.2% 2.7% 2.6%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  0.3 0.4 0.3 0.1 0.5  
Current Ratio  1.2 1.3 1.4 0.7 1.3  
Cash and cash equivalent  0.0 0.0 0.0 0.0 0.0  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  676.5 732.0 1,529.8 -1,522.7 1,632.2  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 -635 -189  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 -615 -189  
EBIT / employee  0 0 0 -635 -231  
Net earnings / employee  0 0 0 -662 -211